Luis Bavestrello

Dr. Luis Bavestrello


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in Revista chilena de infectología
Verified
Journal Article
Open access
PDF file
LBLuis Bavestrello
Luis Bavestrello
ÁMÁngela Cabello M
Ángela Cabello M
Background: The Chilean Ministry of Health has implemented regulatory rules for the consumption of anti-biotics since September 1999, with sales restriction limited only with medical prescription. Aim: To analyze the impact of established regulatory measures from 2000 to 2008. Material and Methods: A retrospective analysis of antibiotics sales in pharmacies from 2000 to 2008 was performed. The information was obtained from the International Marketing System (IMS Health), an auditing system of pharmacy sales. The consumption unit used was the Defined Daily Dose per 1000 inhabitants/day (DDD). Results: From 2000 to 2002 the regulatory rules had a great impact, but since 2002 the antibiotic consumption increased, especially amoxicillin, returning to similar levéis observed in 1998. Conclusions: The regulatory measures had an initial impact, but there was not reinforcement in the time and there was no further control. It is necessary to assume a permanent task and support of the authorities of health to edúcate the population about the implications of the inadequate use of antimicrobials and his effect on the microbial ecology.

5 May 2011
Verified
Journal Article
Closed access
LBLuis Bavestrello
Luis Bavestrello
AMAngela Cabello M
Angela Cabello M

29 January 2009
Verified
Journal Article
Closed access
ACAlberto Fica C
Alberto Fica C
AMAngela Cabello M
Angela Cabello M
CLChrystal Juliet L
Chrystal Juliet L
PDPriscilla Prado D
Priscilla Prado D
LBLuis Bavestrello
Luis Bavestrello

1 December 2008 in Revista chilena de infectología
Verified
Journal Article
Open access
PDF file
ACAlberto Fica C
Alberto Fica C
AMAngela Cabello M
Angela Cabello M
CLChrystal Juliet L
Chrystal Juliet L
PDPriscilla Prado D
Priscilla Prado D
LBLuis Bavestrello
Luis Bavestrello

27 February 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
Mirta Isabel Acuña-ÁvilaMirta Isabel Acuña-Ávila
Mirta Isabel Acuña-Ávila
THTania Herrera
Tania Herrera
DBDona Benadof
Dona Benadof
DADaniela Pavez Azurmendi
Daniela Pavez Azurmendi
LBLuis Bavestrello
Luis Bavestrello
Ruth Rosales ChacónRuth Rosales Chacón
Ruth Rosales Chacón
Antimicrobial Stewardship Programs (ASPs) are a cornerstone strategy to mitigate the global threat of antimicrobial resistance (AMR), primarily driven by inappropriate antimicrobial use. ASPs aim to optimize antimicrobial therapy by ensuring appropriate indication, agent selection, dosing, route of administration, and duration of treatment. Through these interventions, ASPs improve clinical outcomes, reduce adverse drug events, decrease selective pressure for resistant organisms, and contribute to healthcare cost containment. Effective implementation requires a multidisciplinary approach involving physicians, pharmacists, microbiologists, nurses, and information technology specialists, and must be tailored to local epidemiology and healthcare system capacity in accordance with World Health Organization (WHO) recommendations. This narrative review describes the development and evolution of the national antimicrobial stewardship policy in Chile, based on a review of publications indexed in SciELO, official documents from the Ministry of Health (MINSAL), and relevant national legislation. In Chile, antimicrobial stewardship initiatives began in the late 1990s with regulatory measures mandating prescription-only dispensing of antimicrobials and the introduction of national technical standards for rational antimicrobial use. After that, Chile adopted a comprehensive One Health approach and implemented national AMR action plans aligned with WHO strategies. Substantial progress has been achieved across hospital, primary care, veterinary, and aquaculture settings, including expanded ASP coverage, strengthened regulatory frameworks, national surveillance systems for antimicrobial consumption and resistance, and incorporation of stewardship indicators into institutional performance metrics. Despite these advances, challenges related to workforce capacity, technological infrastructure, and long-term monitoring persist and must be addressed to further consolidate national ASP implementation.